TY - JOUR
T1 - The helping older people engage (HOPE) study
T2 - Protocol & COVID modifications for a randomized trial
AU - Van Orden, Kimberly A.
AU - Conwell, Yeates
AU - Chapman, Benjamin P.
AU - Buttaccio, April
AU - VanBergen, Alexandra
AU - Beckwith, Ellen
AU - Santee, Angela
AU - Rowe, Jody
AU - Palumbos, Deborah
AU - Williams, Geoffrey
AU - Messing, Susan
AU - Sörensen, Silvia
AU - Tu, Xin
N1 - Publisher Copyright:
© 2022 The Authors
PY - 2022/12
Y1 - 2022/12
N2 - Objectives: Evidence-based strategies to reduce loneliness in later life are needed because loneliness impacts all domains of health, functioning, and quality of life. Volunteering is a promising strategy, as a large literature of observational studies documents associations between volunteering and better health and well-being. However, relatively few studies have used randomized controlled trials (RCTs) to examine benefits of volunteering, and none have examined loneliness. The primary objective of the Helping Older People Engage (HOPE) study is to examine the social-emotional benefits of a social volunteering program for lonely older adults. This manuscript describes the rationale and design of the trial. Methods: We are randomly assigning adults aged 60 or older (up to 300) who report loneliness to 12 months of either AmeriCorps Seniors volunteering program or an active control (self-guided life review). Co-primary outcomes are assessed via self-report—loneliness (UCLA Loneliness Scale) and quality of life (WHOQOL-Bref). Enrollment was completed in May 2022 and follow-up assessments will continue through May 2023, with completion of primary outcomes soon thereafter. Conclusions: Since older adults who report loneliness are less likely to actively seek out volunteering opportunities, if results support efficacy of volunteering for reducing loneliness, dissemination and scaling up efforts may involve connecting primary care patients who are lonely with AmeriCorps Seniors through aging services agencies. This RCT is registered at clinicaltrials.gov (NCT03343483).
AB - Objectives: Evidence-based strategies to reduce loneliness in later life are needed because loneliness impacts all domains of health, functioning, and quality of life. Volunteering is a promising strategy, as a large literature of observational studies documents associations between volunteering and better health and well-being. However, relatively few studies have used randomized controlled trials (RCTs) to examine benefits of volunteering, and none have examined loneliness. The primary objective of the Helping Older People Engage (HOPE) study is to examine the social-emotional benefits of a social volunteering program for lonely older adults. This manuscript describes the rationale and design of the trial. Methods: We are randomly assigning adults aged 60 or older (up to 300) who report loneliness to 12 months of either AmeriCorps Seniors volunteering program or an active control (self-guided life review). Co-primary outcomes are assessed via self-report—loneliness (UCLA Loneliness Scale) and quality of life (WHOQOL-Bref). Enrollment was completed in May 2022 and follow-up assessments will continue through May 2023, with completion of primary outcomes soon thereafter. Conclusions: Since older adults who report loneliness are less likely to actively seek out volunteering opportunities, if results support efficacy of volunteering for reducing loneliness, dissemination and scaling up efforts may involve connecting primary care patients who are lonely with AmeriCorps Seniors through aging services agencies. This RCT is registered at clinicaltrials.gov (NCT03343483).
KW - Aging
KW - Loneliness
KW - Older adult
KW - Quality of life
KW - Social connection
KW - Volunteerism
UR - http://www.scopus.com/inward/record.url?scp=85143551613&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85143551613&partnerID=8YFLogxK
U2 - 10.1016/j.conctc.2022.101040
DO - 10.1016/j.conctc.2022.101040
M3 - Article
C2 - 36479062
AN - SCOPUS:85143551613
SN - 2451-8654
VL - 30
JO - Contemporary Clinical Trials Communications
JF - Contemporary Clinical Trials Communications
M1 - 101040
ER -